LeMaitre Vascular (LMAT) Could Be 26% Undervalued On Mixed Valuation Views
LeMaitre Vascular (LMAT) has seen its share price drop by about 17% in the last month, prompting questions about its valuation. While one narrative suggests the stock is 25.6% undervalued with a fair value of $110, driven by an expanding patient population and revenue โฆ